0.7359
price down icon1.12%   -0.0083
after-market Handel nachbörslich: .74 0.0041 +0.56%
loading

Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
24.21%
2.1487
1.7299 1.51 1.5814 2.358
Operating Income/Loss
3.55%
-3.8109
-3.6802 -3.2596 -3.0046 -3.945
Nonoperating Income/Loss
18.98%
0.0947
0.1169 0.0819 0.00477 0.0788
Income/Loss From Continuing Operations Before Tax
4.29%
-3.7162
-3.5632 -3.1777 -2.9998 -3.8662
Income/Loss From Continuing Operations After Tax
4.29%
-3.7162
-3.5632 -3.1777 -2.9998 -3.8662
Net Income/Loss
4.29%
-3.7162
-3.5632 -3.1777 -2.9998 -3.8662
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
155.12%
5.6413
2.2112 0.0528 1.0441 1.0433
Diluted Average Shares
155.12%
5.6413
2.2112 0.0528 1.0441 1.0433
Basic Earnings Per Share
59.01%
-0.66
-1.61 - - -
Diluted Earnings Per Share
59.01%
-0.66
-1.61 - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):